American journal of perinatology
-
Randomized Controlled Trial
Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.
This study aims to evaluate whether magnesium sulfate administration for neuroprotection prolongs latency in women with preterm premature rupture of membranes (PPROM) between 24 and 31(6/7) weeks' gestation. ⋯ Magnesium sulfate administration given for neuroprotection in women with a singleton gestation with PPROM and without labor before 32 weeks does not impact latency.